Actavis PLC (ACT.N)

ACT.N on New York Stock Exchange

258.49USD
20 Nov 2014
Price Change (% chg)

$-7.55 (-2.84%)
Prev Close
$266.04
Open
$265.00
Day's High
$267.16
Day's Low
$257.43
Volume
851,186
Avg. Vol
412,671
52-wk High
$270.33
52-wk Low
$156.40

ACT.N

Chart for ACT.N

About

Actavis PLC, is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes.... (more)

Overall

Beta: 0.30
Market Cap (Mil.): $68,515.65
Shares Outstanding (Mil.): 265.06
Dividend: --
Yield (%): --

Financials

  ACT.N Industry Sector
P/E (TTM): -- 38.20 39.19
EPS (TTM): -4.18 -- --
ROI: -3.50 17.90 17.21
ROE: -6.36 18.65 18.13
Search Stocks

Valeant slashes stake in Allergan after losing bid

- Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.

5:45am IST

Valeant slashes stake in Allergan after losing bid

Nov 20 - Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker.

5:44am IST

Suvretta's Cowen says Actavis stock could nearly double

NEW YORK - After months of fending off a hostile bid, Allergan Inc Chief Executive David Pyott made the right call in selling to rival Actavis Plc , whose stock price could nearly double in the next two years, a prominent investor said on Wednesday.

20 Nov 2014

S&P 500 hits record, healthcare leads gains

NEW YORK - U.S. stocks rose in afternoon trading on Tuesday, lifting the S&P 500 to a record high as healthcare shares extended gains.

19 Nov 2014

Ackman supports Allergan's $66 billion sale to Actavis

- Activist investor William Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder meeting.

19 Nov 2014

UPDATE 1-Ackman supports Allergan's $66 billion sale to Actavis

Nov 18 - Activist investor William Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder meeting.

19 Nov 2014

US STOCKS-S&P 500 hits record as Actavis rallies

* SunEdison, TerraForm rally on entrance to U.S. wind power market

18 Nov 2014

S&P 500 hits record again; Actavis rallies

NEW YORK - U.S. stocks rose on Tuesday, lifting the S&P 500 to a record high, boosted by healthcare after Actavis' acquisition of Allergan triggered bullish analyst notes.

18 Nov 2014

Ackman says supports Allergan's $66 billion sale to Actavis -CNBC

Nov 18 - Activist investor William Ackman is supporting the $66 billion deal in which Actavis PLC will buy Allergan Inc and plans to withdraw from an Allergan special shareholder meeting he had planned, CNBC television reported on Tuesday.

18 Nov 2014

US STOCKS-S&P 500 hits record again; Actavis rallies

* SunEdison, TerraForm rally on entrance to U.S. wind power market

18 Nov 2014

Earnings vs. Estimates

Search Stocks